Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes
Authors
Keywords
-
Journal
ONCOGENE
Volume 34, Issue 28, Pages 3640-3650
Publisher
Springer Nature
Online
2014-09-29
DOI
10.1038/onc.2014.300
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210
- (2014) Haopeng Wang et al. NATURE IMMUNOLOGY
- Cytokine functions of TIMP-1
- (2013) Christian Ries CELLULAR AND MOLECULAR LIFE SCIENCES
- WSS25 inhibits Dicer, downregulating microRNA-210, which targets Ephrin-A3, to suppress human microvascular endothelial cell (HMEC-1) tube formation
- (2013) Fei Xiao et al. GLYCOBIOLOGY
- The perivascular niche regulates breast tumour dormancy
- (2013) Cyrus M. Ghajar et al. NATURE CELL BIOLOGY
- Exosomal Signaling during Hypoxia Mediates Microvascular Endothelial Cell Migration and Vasculogenesis
- (2013) Carlos Salomon et al. PLoS One
- Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development
- (2013) P. Kucharzewska et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteolytic factors in exosomes
- (2013) Masayuki Shimoda et al. PROTEOMICS
- In papillary thyroid carcinoma, TIMP-1 expression correlates with BRAF V600E mutation status and together with hypoxia-related proteins predicts aggressive behavior
- (2013) Marius I. Ilie et al. VIRCHOWS ARCHIV
- MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines
- (2013) S Grosso et al. Cell Death & Disease
- Hypoxic enhancement of exosome release by breast cancer cells
- (2012) Hamish W King et al. BMC CANCER
- Hypoxia-Inducible miR-210 Regulates the Susceptibility of Tumor Cells to Lysis by Cytotoxic T Cells
- (2012) M. Z. Noman et al. CANCER RESEARCH
- Up-regulation of miR-210 by vascular endothelial growth factor inex vivoexpanded CD34+ cells enhances cell-mediated angiogenesis
- (2012) Mohamad Amer Alaiti et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model
- (2012) Yifeng Xia et al. NATURE CELL BIOLOGY
- TIMP-1 Induces an EMT-Like Phenotypic Conversion in MDCK Cells Independent of Its MMP-Inhibitory Domain
- (2012) Young Suk Jung et al. PLoS One
- On the Pro-Metastatic Stress Response to Cancer Therapies: Evidence for a Positive Co-Operation between TIMP-1, HIF-1α, and miR-210
- (2012) Haissi Cui et al. Frontiers in Pharmacology
- Targeting NF-κB and HIF-1 Pathways for the Treatment of Cancer: Part II
- (2011) Jacek Wilczynski et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Hypoxia-inducible MicroRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma
- (2011) Qiao Ying et al. HEPATOLOGY
- miR-210: The Master Hypoxamir
- (2011) YUK C. CHAN et al. MICROCIRCULATION
- A Hypoxia-Induced Positive Feedback Loop Promotes Hypoxia-Inducible Factor 1 Stability through miR-210 Suppression of Glycerol-3-Phosphate Dehydrogenase 1-Like
- (2011) T. J. Kelly et al. MOLECULAR AND CELLULAR BIOLOGY
- Tissue inhibitor of metalloproteinase-1 promotes NIH3T3 fibroblast proliferation by activating p-Akt and cell cycle progression
- (2011) Yang Lu et al. MOLECULES AND CELLS
- Full-Length L1CAM and Not Its Δ2Δ27 Splice Variant Promotes Metastasis through Induction of Gelatinase Expression
- (2011) Stephanie Hauser et al. PLoS One
- Exosome Secretion: Molecular Mechanisms and Roles in Immune Responses
- (2011) Angélique Bobrie et al. TRAFFIC
- Tissue inhibitors of metalloproteinases
- (2011) Gillian Murphy GENOME BIOLOGY
- The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
- (2010) Keith Brew et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer
- (2010) Antonis Giannakakis et al. CANCER BIOLOGY & THERAPY
- MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT
- (2010) Zhan Zhang et al. CELL CYCLE
- MicroRNA-210: A unique and pleiotropic hypoxamir
- (2010) Stephen Y. Chan et al. CELL CYCLE
- miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity
- (2010) M-P Puisségur et al. CELL DEATH AND DIFFERENTIATION
- Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α
- (2010) Florian Schelter et al. CLINICAL & EXPERIMENTAL METASTASIS
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-210 Regulates Cancer Cell Proliferation through Targeting Fibroblast Growth Factor Receptor-like 1 (FGFRL1)
- (2010) Soken Tsuchiya et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypoxic Tumor Cell Modulates Its Microenvironment to Enhance Angiogenic and Metastatic Potential by Secretion of Proteins and Exosomes
- (2010) Jung Eun Park et al. MOLECULAR & CELLULAR PROTEOMICS
- Hypoxia-Inducible Factors and the Response to Hypoxic Stress
- (2010) Amar J. Majmundar et al. MOLECULAR CELL
- In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract
- (2010) Irina Arnaoutova et al. Nature Protocols
- Let-7 MicroRNA Family Is Selectively Secreted into the Extracellular Environment via Exosomes in a Metastatic Gastric Cancer Cell Line
- (2010) Keiichi Ohshima et al. PLoS One
- MiR-210 – micromanager of the hypoxia pathway
- (2010) Xin Huang et al. TRENDS IN MOLECULAR MEDICINE
- Avoiding spam in the proteolytic internet: Future strategies for anti-metastatic MMP inhibition
- (2009) Achim Krüger et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- MicroRNA Regulation of DNA Repair Gene Expression in Hypoxic Stress
- (2009) M. E. Crosby et al. CANCER RESEARCH
- MicroRNA-210 Controls Mitochondrial Metabolism during Hypoxia by Repressing the Iron-Sulfur Cluster Assembly Proteins ISCU1/2
- (2009) Stephen Y. Chan et al. Cell Metabolism
- Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer
- (2009) Guilherme Rabinowits et al. Clinical Lung Cancer
- HIF-1: upstream and downstream of cancer metabolism
- (2009) Gregg L Semenza CURRENT OPINION IN GENETICS & DEVELOPMENT
- Ischemic Preconditioning Augments Survival of Stem Cells via miR-210 Expression by Targeting Caspase-8-associated Protein 2
- (2009) Ha Won Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation
- (2009) Xin Huang et al. MOLECULAR CELL
- Fibroblasts potentiate blood vessel formation partially through secreted factor TIMP-1
- (2008) Hua Liu et al. ANGIOGENESIS
- The Role of Tissue Inhibitors of Metalloproteinases in Tumorigenesis and Metastasis
- (2008) William Cruz-Munoz et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3
- (2008) Pasquale Fasanaro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
- (2008) William G. Kaelin et al. MOLECULAR CELL
- Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities
- (2008) W. G. Stetler-Stevenson Science Signaling
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started